MARZARI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 7.466
EU - Europa 2.411
AS - Asia 660
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 7
AF - Africa 3
OC - Oceania 1
Totale 10.564
Nazione #
US - Stati Uniti d'America 7.450
UA - Ucraina 647
SE - Svezia 601
IT - Italia 370
CN - Cina 301
FI - Finlandia 226
HK - Hong Kong 181
TR - Turchia 141
GB - Regno Unito 124
DE - Germania 107
BG - Bulgaria 96
IE - Irlanda 95
FR - Francia 63
BE - Belgio 27
CH - Svizzera 22
CA - Canada 16
EU - Europa 15
IN - India 10
NL - Olanda 8
SG - Singapore 7
KR - Corea 6
RU - Federazione Russa 6
BR - Brasile 5
CZ - Repubblica Ceca 4
JP - Giappone 4
MY - Malesia 3
RO - Romania 3
SN - Senegal 3
VN - Vietnam 3
GR - Grecia 2
NO - Norvegia 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
LU - Lussemburgo 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PY - Paraguay 1
Totale 10.564
Città #
Woodbridge 1.071
Ann Arbor 1.016
Houston 886
Fairfield 842
Jacksonville 558
Chandler 499
Ashburn 480
Wilmington 415
Seattle 342
Cambridge 281
Princeton 192
Hong Kong 181
Izmir 139
Beijing 104
Sofia 96
Dublin 94
Boardman 79
Trieste 70
Milan 64
Dearborn 61
Bremen 47
Düsseldorf 42
Helsinki 36
San Diego 36
Falls Church 30
Brussels 25
Chicago 25
Verona 22
Jinan 20
Bern 19
Sacile 19
Des Moines 18
Nanjing 18
Guangzhou 16
Norwalk 16
Buffalo 15
Toronto 11
Hefei 10
Kunming 10
Mestre 10
Washington 9
Andover 8
Auburn Hills 8
Columbus 8
Fremont 8
Phoenix 8
Shenyang 8
Redwood City 7
Cascina 6
Grafing 6
London 6
Pune 6
Seoul 6
Chongqing 5
Hangzhou 5
Los Angeles 5
Rome 5
Brno 4
Fuzhou 4
Hebei 4
San Francisco 4
Taizhou 4
Udine 4
Dakar 3
Detroit 3
Groningen 3
Hanoi 3
Indiana 3
Moscow 3
Nanchang 3
Ottawa 3
Shanghai 3
São Paulo 3
Tianjin 3
Tokyo 3
Wuhan 3
Chengdu 2
Edinburgh 2
Kocaeli 2
Kuala Lumpur 2
Leawood 2
Mantova 2
Maribor 2
Montreal 2
Munich 2
Paris 2
San Mateo 2
Shaoxing 2
Taiyuan 2
Torre Del Greco 2
Treviso 2
Zhengzhou 2
Zurich 2
Amsterdam 1
Antwerpen 1
Apo 1
Asunción 1
Athens 1
Auckland 1
Augusta 1
Totale 8.133
Nome #
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 215
Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats. 201
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 190
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 179
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 179
The gut as site of production of autoimmune antibodies. 178
Autoantibodies as predictors of disease. 175
Using archaeal histones for precise DNA fragmentation , 20: 267-271 (2007) 174
Anti transglutaminase antibodies cause ataxia in mice. 173
Anti-transglutaminase antibodies and age. 169
null 163
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 161
Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of human high mobility group I-C protein 156
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab. 155
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 154
A reliable screening procedure for coeliac disease in clinical practice. 153
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 152
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 151
Dual sugar gut-permeability testing on blood drop in animal models. 149
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 148
Development of a novel rapid non-invasive screening test for coeliac disease. 142
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 141
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 141
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 140
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5 140
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 138
Gluten ataxia: passive transfer in a mouse model. 131
Profiling the Autoantibody Repertoire by Screening Phage-Displayed Human cDNA Libraries 131
Antibodies in proteomics I: generating antibodies 129
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 126
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 125
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 125
Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 124
Anti-idiotypic response in mice expressing human autoantibodies. 123
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. 122
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 119
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 119
null 119
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 117
null 114
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 114
Selection and characterization of a novel agonistic human recombinant anti-TRAIL-R2 minibody with anti-leukemic activity. 113
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. 110
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies 110
Profiling celiac disease antibody repertoire 110
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 106
Patterning of fibronectin using laser writer for force measurement in cells 104
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 104
Phage display of Bacillus thuringiensis CryIA(a) insecticidal protein 102
Anti-transglutaminase and age, Clinical Chemestry 101
null 100
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 99
A method for selecting phage display open reading frames on phages 97
null 97
Protective role of anti-idiotypic network in celiac disease prone subjects 97
Immunochemical characterisation of a murine monoclonal anti-idiotypic antibody 97
Characterizing monoclonal antibody epitopes by filtered gene fragment phagedisplay. 96
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 96
Simple scale-up of recombinant antibody production using an UCOE containing vector 96
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 95
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 95
Charecterization of tissue transglutaminase auto-antigenic response using cloned structural domains 95
Anti-alpha enolase autoantibodies in coeliac disease 93
Protective role of anti-idiotypic network in celiac disease prone subjects 92
Expression of a cloned Bacillus thuringiensis delta-endotoxin gene in Bacillus subtilis 91
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 90
Serum immunoglobulin A and G, and monoclonal antibodies anti-tissue transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ 86
Human monoclonal anti-transglutaminase antibodies from celiac patients inhibit cell induced apoptosis 86
Anti tTG autoantibodies crossreacting with brain structures are produced in the intestine in celiac patient with equilibrium disorder 86
Protective role of anti-idiotypic network in celiac disease prone subjects 83
Identification of new antigen candidate of Multiple Sclerosis using an ORF selected phage display library 82
Antibodies anti-c5 component of the complement system and their use 81
Rapid characterization of VH-5 family specific anti-tTG intestinal antibodies in celiac and autoimmune patients 80
Small, antibacterial and large, inactive peptides of neutrophil granules share immunoreactivity to a monoclonal antibody. 79
A rat atlas to characterise anti brain humoral resoponse in patients with gluten sensitivity and celiac disease 79
"Recombinant antibodies against human type ii transglutaminase and uses thereof" 78
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 77
J Pediatr Gastroenterol Nutr 1990 Oct;11(3):337-41 A dot immunobinding assay to detect anti-alpha-gliadin antibodies in celiac disease. 75
“Impianto di cellule epiteliali amniotiche umane crioconservate in un soggetto affetto da malattia di Niemann-Pick tipo B.” 75
RECOMBINANT ANTIBODIES AGAINST CD55 AND CD59 AND USES THEREOF 72
Human tissue transglutaminase ELISA: a powerful mass screening diagnostic assay for symptomatic and asymptomatic celiac disease. 71
Malattia celiaca: tra passato e futuro 70
Intestinal mucosa anti-transglutaminase antibodies in early stage of gluten intolerance 69
Creation of a mouse model of coeliac disease by in vivo long term expression of disease specific anti trasnglutaminase antibody 68
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ 68
Coeliac disease risk in patients with idiopathic dilated cardiomiopathy 68
Salivary anti-human transglutaminase in the diagnosis of coeliac disease 68
Filtering out open reading frames 63
Correlation between anti-transglutaminase antibodies and healthy status in the general population 63
Increasing titres of anti-human-transglutaminase antibodies with age in healthy population 62
Phage antibody library from celiac disease patient. 57
Identification of novel celiac disease autoantigens by combined phage display and protein array technology 57
Monoclonal anti-transglutaminase antibodies from celiac disease patients inhibit cell-induced apoptosis 55
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet 52
Oral mucosa precedes the intestine on the gluten-dependent immune response 51
Antibodies in proteomics 37
Cryptic gluten intolerance in type 1 diabetes: identifying suitable candidates for gluten-free diet 35
Predicting antigenic peptides suitable for the selection of phage antibodies 19
Selecting Open Reading Frames from DNA 19
Molecular dissection of the tissue transglutaminase antoantibody response in celiac disease 17
Totale 10.729
Categoria #
all - tutte 25.928
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.928


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019724 0 0 0 0 0 0 0 0 0 0 504 220
2019/20202.086 114 90 101 392 134 290 220 271 181 90 145 58
2020/20211.447 136 84 201 171 81 176 52 127 58 171 50 140
2021/20221.067 39 71 36 114 47 103 45 37 123 105 93 254
2022/20231.509 171 202 114 215 174 274 2 116 164 8 52 17
2023/2024670 51 61 42 77 84 73 117 145 8 7 5 0
Totale 10.748